Literature DB >> 22350475

Preoperative localizing studies for initial parathyroidectomy in MEN1 syndrome: is there any benefit?

Naris Nilubol1, Lee Weinstein, William F Simonds, Robert T Jensen, Giao Q Phan, Marybeth S Hughes, Steven K Libutti, Stephen Marx, Electron Kebebew.   

Abstract

BACKGROUND: The objective of the present study was to evaluate the utility of preoperative localizing studies in patients with MEN1 undergoing initial bilateral neck exploration (BNE) and parathyroidectomy for pHPT.
METHODS: We performed a retrospective analysis of patients diagnosed with MEN1 who underwent initial parathyroidectomy between December 1993 and December 2010. Results of preoperative localizing studies were compared with intraoperative findings and outcome.
RESULTS: Sixty patients with MEN1 (32 females and 28 males) underwent initial subtotal parathyroidectomy. The median age at the time of surgery was 33 years (range: 13-78 years). Fifty-three patients had one or more positive localizing study results. Neck ultrasonography, sestamibi scan, parathyroid protocol computed tomography scan, and neck and mediastinum magnetic resonance imaging were performed in 93, 91, 32, and 19% of patients, respectively. Fifty-three patients (88%) had cervical thymectomy. Twenty patients had 24 ectopic parathyroid glands; 18 glands were in the thymus (75%). Preoperative localizing studies identified 9 of 24 ectopic parathyroid glands (38%), including 4 ectopic glands outside the thymus in 4 patients (7%); 3 were detected by ultrasonography. There were no supernumerary glands identified on preoperative localizing studies.
CONCLUSIONS: In patients with MEN1, preoperative localizing studies identified a subset of ectopic glands (38%). Preoperative localizing studies may alter the operative approach in 7% of patients. Ultrasonography can detect most ectopic parathyroid glands outside thymus. This suggests that routine preoperative localizing studies to identify ectopic and supernumerary enlarged parathyroid glands is not useful in the majority of patients with MEN1 undergoing bilateral neck exploration and subtotal parathyroidectomy with cervical thymectomy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22350475     DOI: 10.1007/s00268-012-1451-1

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  31 in total

Review 1.  Familial multiple endocrine neoplasia type I: a new look at pathophysiology.

Authors:  M L Brandi; S J Marx; G D Aurbach; L A Fitzpatrick
Journal:  Endocr Rev       Date:  1987-11       Impact factor: 19.871

2.  Multiple endocrine neoplasia type 1: a 10-year prospective screening study in four kindreds.

Authors:  B Skogseid; B Eriksson; G Lundqvist; L E Lörelius; J Rastad; L Wide; G Akerström; K Oberg
Journal:  J Clin Endocrinol Metab       Date:  1991-08       Impact factor: 5.958

3.  Primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1: comparison with sporadic parathyroid adenomas.

Authors:  M Katai; A Sakurai; Y Ikeo; K Hashizume
Journal:  Horm Metab Res       Date:  2001-08       Impact factor: 2.936

4.  Frequency of ectopic and supernumerary intrathymic parathyroid glands in patients with renal hyperparathyroidism: analysis of 461 patients undergoing initial parathyroidectomy with bilateral cervical thymectomy.

Authors:  Ralph Schneider; Jens Waldmann; Annette Ramaswamy; Emilio Domínguez Fernández; Detlef K Bartsch; Katja Schlosser
Journal:  World J Surg       Date:  2011-06       Impact factor: 3.352

5.  Screening of the Men1 gene and discovery of germ-line and somatic mutations in apparently sporadic parathyroid tumors.

Authors:  S Uchino; S Noguchi; M Sato; H Yamashita; H Yamashita; S Watanabe; T Murakami; M Toda; A Ohshima; T Futata; T Mizukoshi; E Koike; K Takatsu; K Terao; S Wakiya; M Nagatomo; M Adachi
Journal:  Cancer Res       Date:  2000-10-01       Impact factor: 12.701

6.  Subtotal parathyroidectomy for primary chief cell hyperplasia of the multiple endocrine neoplasia type I syndrome.

Authors:  R A Prinz; O I Gamvros; D Sellu; J A Lynn
Journal:  Ann Surg       Date:  1981-01       Impact factor: 12.969

7.  Usefulness of the combination of ultrasonography and 99mTc-sestamibi scintigraphy in the preoperative evaluation of uremic secondary hyperparathyroidism.

Authors:  Carlo Vulpio; Maurizio Bossola; Annamaria De Gaetano; Giulia Maresca; Isabella Bruno; Guido Fadda; Francesca Morassi; Sabina C Magalini; Alessandro Giordano; Marco Castagneto
Journal:  Head Neck       Date:  2010-09       Impact factor: 3.147

8.  Primary hyperparathyroidism in familial multiple endocrine neoplasia type I. Long-term follow-up of serum calcium levels after parathyroidectomy.

Authors:  R Rizzoli; J Green; S J Marx
Journal:  Am J Med       Date:  1985-03       Impact factor: 4.965

9.  The ectopic parathyroid adenoma: a cost justification for routine preoperative localization with technetium Tc 99m sestamibi scan.

Authors:  R A Sofferman; M H Nathan
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1998-06

10.  Surgical approach to the patient with familial hyperparathyroidism.

Authors:  Lindi H VanderWalde; Philip I Haigh
Journal:  Curr Treat Options Oncol       Date:  2006-07
View more
  7 in total

1.  Aortopulmonary window parathyroid gland causing primary hyperparathyroidism in men type 1 syndrome.

Authors:  Francesco Tonelli; Carlo Biagini; Francesco Giudici; Federica Cioppi; Maria Luisa Brandi
Journal:  Fam Cancer       Date:  2016-01       Impact factor: 2.375

Review 2.  Less Than Subtotal Parathyroidectomy for Multiple Endocrine Neoplasia Type 1 Primary Hyperparathyroidism: A Systematic Review and Meta-Analysis.

Authors:  Damien Bouriez; Caroline Gronnier; Magalie Haissaguerre; Antoine Tabarin; Haythem Najah
Journal:  World J Surg       Date:  2022-06-29       Impact factor: 3.282

3.  Parathyroid disorder and concomitant thyroid cancer in patients with multiple endocrine neoplasia type 1: A retrospective cohort study.

Authors:  Ying Wang; Sheng Cai; He Liu; Rui-Na Zhao; Xing-Jian Lai; Ke Lv; Yu-Xin Jiang; Jian-Chu Li
Journal:  Medicine (Baltimore)       Date:  2021-09-10       Impact factor: 1.817

4.  Familial isolated primary hyperparathyroidism associated with germline GCM2 mutations is more aggressive and has a lesser rate of biochemical cure.

Authors:  Mustapha El Lakis; Pavel Nockel; Bin Guan; Sunita Agarwal; James Welch; William F Simonds; Stephen Marx; Yulong Li; Naris Nilubol; Dhaval Patel; Lily Yang; Roxanne Merkel; Electron Kebebew
Journal:  Surgery       Date:  2017-11-03       Impact factor: 3.982

5.  Ultrasonographic evaluation of parathyroid hyperplasia in multiple endocrine neoplasia type 1: Positive correlation between parathyroid volume and circulating parathyroid hormone concentration.

Authors:  Hiroyuki Tamiya; Megumi Miyakawa; Akira Takeshita; Daishu Miura; Yasuhiro Takeuchi
Journal:  J Bone Miner Metab       Date:  2014-09-17       Impact factor: 2.626

6.  Genetic and clinical features of multiple endocrine neoplasia types 1 and 2.

Authors:  C Romei; E Pardi; F Cetani; R Elisei
Journal:  J Oncol       Date:  2012-11-08       Impact factor: 4.375

7.  Intraoperative Decision-Making and Technical Aspects of Parathyroidectomy in Young Patients With MEN1 Related Hyperparathyroidism.

Authors:  Priscilla F Nobecourt; Jonathan Zagzag; Elliot A Asare; Nancy D Perrier
Journal:  Front Endocrinol (Lausanne)       Date:  2018-10-16       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.